Ahmed Farah

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2018 · 425 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Unit +6

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2020 · 243 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Drug-coated Balloons +6

Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial

Bruno Scheller, Tuomas T. Rissanen, Ahmed Farah et al. · Circulation Cardiovascular Interventions · 2022 · 64 citations

Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents

Jochen Wöhrle, Bruno Scheller, Julia Seeger et al. · JACC: Cardiovascular Interventions · 2021 · 52 citations

Diabetes Management, Cardiovascular Disease, Diabetes +8

Incidence and predictors of ventricular arrhythmias after ST-segment elevation myocardial infarction

Marc‐Alexander Ohlow, J. Christoph Geller, Stefan Richter et al. · The American Journal of Emergency Medicine · 2011 · 32 citations

Ventricular Arrhythmias, Cardiovascular Disease, Myocardial Infarction +8